Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

OBJECTIVE: We assessed CSF levels of the light chain subunit of neurofilaments (NfL) at baseline and after fingolimod therapy or placebo in patients with relapsing-remitting multiple sclerosis (RRMS). Changes in NfL levels were also correlated with relapse and MRI outcomes. METHODS: CSF samples were...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurology
Главные авторы: Kuhle, Jens, Disanto, Giulio, Lorscheider, Johannes, Stites, Tracy, Chen, Yu, Dahlke, Frank, Francis, Gordon, Shrinivasan, Anupama, Radue, Ernst-Wilhelm, Giovannoni, Gavin, Kappos, Ludwig
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409586/
https://ncbi.nlm.nih.gov/pubmed/25809304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001491
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы